Susquehanna International Group, LLP Harrow Health, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Harrow Health, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 277,900 shares of HROW stock, worth $10.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

277,900

Previous 43,644 536.74%

Holding current value

$10.2 Million

Previous $911,000 1271.46%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$10.0 - $21.64 $973,530 - $2.11 Million	-97,353 Reduced 69.05%	43,644 $911,000
Q1 2024 May 07, 2024	BUY	$9.3 - $13.23 $209,854 - $298,534	22,565 Added 19.05%	140,997 $1.87 Million
Q4 2023 Feb 14, 2024	SELL	$8.1 - $16.36 $627,247 - $1.27 Million	-77,438 Reduced 39.54%	118,432 $1.33 Million
Q3 2023 Nov 14, 2023	BUY	$14.03 - $22.08 $2.59 Million - $4.07 Million	184,378 Added 1604.4%	195,870 $2.81 Million
Q2 2023 Aug 11, 2023	SELL	$17.37 - $28.08 $5.59 Million - $9.03 Million	-321,729 Reduced 96.55%	11,492 $218,000
Q1 2023 May 16, 2023	BUY	$13.84 - $21.46 $2.88 Million - $4.46 Million	207,939 Added 165.98%	333,221 $7.05 Million
Q4 2022 Feb 14, 2023	BUY	$10.28 - $14.78 $852,931 - $1.23 Million	82,970 Added 196.09%	125,282 $1.85 Million
Q3 2022 Nov 14, 2022	SELL	$6.57 - $24.88 $20,964 - $79,392	-3,191 Reduced 7.01%	42,312 $511,000
Q2 2022 Aug 15, 2022	SELL	$5.75 - $7.74 $735,735 - $990,363	-127,954 Reduced 73.77%	45,503 $331,000
Q1 2022 May 16, 2022	BUY	$6.77 - $8.66 $159,968 - $204,627	23,629 Added 15.77%	173,457 $1.18 Million
Q4 2021 Feb 14, 2022	BUY	$8.5 - $12.0 $28,619 - $40,404	3,367 Added 2.3%	149,828 $1.3 Million
Q3 2021 Nov 15, 2021	BUY	$6.99 - $10.6 $802,025 - $1.22 Million	114,739 Added 361.7%	146,461 $1.33 Million
Q2 2021 Aug 11, 2021	BUY	$6.68 - $11.07 $141,288 - $234,141	21,151 Added 200.09%	31,722 $295,000
Q1 2021 May 17, 2021	SELL	$6.26 - $11.03 $12,607 - $22,214	-2,014 Reduced 16.0%	10,571 $71,000
Q4 2020 Feb 16, 2021	SELL	$4.76 - $6.93 $368,209 - $536,070	-77,355 Reduced 86.01%	12,585 $86,000
Q2 2020 Aug 14, 2020	SELL	$3.61 - $6.47 $740,154 - $1.33 Million	-205,029 Reduced 69.51%	89,940 $469,000
Q1 2020 May 15, 2020	BUY	$3.5 - $7.31 $660,579 - $1.38 Million	188,737 Added 177.66%	294,969 $1.13 Million
Q4 2019 Feb 14, 2020	SELL	$4.6 - $7.88 $778,890 - $1.33 Million	-169,324 Reduced 61.45%	106,232 $826,000
Q3 2019 Nov 14, 2019	BUY	$4.89 - $8.0 $1.25 Million - $2.05 Million	256,320 Added 1332.5%	275,556 $1.55 Million
Q2 2019 Aug 16, 2019	BUY	$4.2 - $8.7 $22,486 - $46,579	5,354 Added 38.57%	19,236 $167,000
Q2 2019 Aug 14, 2019	SELL	$4.2 - $8.7 $652,134 - $1.35 Million	-155,270 Reduced 91.79%	13,882 $121,000
Q1 2019 May 15, 2019	BUY	$4.75 - $7.1 $803,472 - $1.2 Million	169,152 New	169,152 $842,000

Others Institutions Holding HROW

# of Institutions

177

Shares Held

21.4M

Call Options Held

845K

Put Options Held

717K

View Full List

About HARROW HEALTH, INC.

Ticker HROW
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 27,070,000
Market Cap $992M
Description
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company tha...

More about HROW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Harrow Health, Inc. Transaction History